The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy

被引:46
|
作者
Hodgson, Kate A. [1 ]
Huynh, Julie [1 ]
Ibrahim, Laila F. [1 ]
Sacks, Bronwyn [1 ]
Golshevsky, Daniel [1 ]
Layley, Michael [1 ]
Spagnolo, Mark [1 ]
Raymundo, Chin-Mae [1 ]
Bryant, Penelope A. [1 ,2 ,3 ,4 ]
机构
[1] Royal Childrens Hosp Melbourne, RCH Home Dept, Parkville, Vic, Australia
[2] Royal Childrens Hosp Melbourne, Dept Gen Med, Infect Dis Unit, Parkville, Vic, Australia
[3] Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Clin Paediat Grp, Parkville, Vic, Australia
[4] Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic, Australia
关键词
RISK FEBRILE NEUTROPENIA; ANTIBIOTIC-THERAPY; CYSTIC-FIBROSIS; CHILDREN; HOME; MANAGEMENT; METAANALYSIS; CHILDHOOD; CARE;
D O I
10.1136/archdischild-2015-309731
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective Outpatient parenteral antimicrobial therapy (OPAT) is increasingly used to treat children at home, but studies in children are scarce. We aimed to describe the use, appropriateness and outcomes of OPAT in children. Design This was a 12-month prospective observational study. Setting The hospital-in-the-home programme of The Royal Children's Hospital Melbourne. Patients All patients receiving OPAT. Interventions Data were collected including demographics, diagnosis, type of venous access and antibiotic choice. Main outcome measures Length of stay, adverse events, readmission rate and appropriateness of antibiotic use. Results 228 patients received OPAT in 251 episodes. The median age was 7.4 years (range 1 week to 21 years), with 22 patients (10%) under 1 year. The most frequent diagnoses were exacerbation of cystic fibrosis (17%), urinary tract infection (12%) and cellulitis (9%). Most patients were transferred from the ward, but 18% were transferred directly from the emergency department, the majority with skin and soft-tissue infection (66%). Venous access was most commonly peripherally inserted central catheter (29%) and peripheral cannula (29%). 309 parenteral antibiotics were prescribed, most frequently ceftriaxone (28%) and gentamicin (19%). The majority of antibiotics (72%) were prescribed appropriately. However, 6% were deemed an inappropriate choice for the indication and 26% had inappropriate dose or duration. The incidence of central line-associated bloodstream infections was 0.9%. The unplanned readmission rate was 4%, with low rates of OPAT-related adverse events. Three children (1%) had an inadequate clinical response. Conclusions OPAT is a safe and effective way of providing antibiotics to children. Despite high rates of appropriate antibiotic use, improvements can still be made.
引用
收藏
页码:886 / 893
页数:8
相关论文
共 50 条
  • [21] Are We Ready for an Outpatient Parenteral Antimicrobial Therapy Bundle? A Critical Appraisal of the Evidence
    Muldoon, Eavan G.
    Snydman, David R.
    Penland, Elizabeth C.
    Allison, Geneve M.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (03) : 419 - 424
  • [22] Outpatient Parenteral Antimicrobial Therapy in Young Infants
    Krah, Nathan M.
    Olson, Jared
    Thorell, Emily A.
    Esquibel, Lawanda
    Osguthorpe, Russell J.
    Pavia, Andrew T.
    Hersh, Adam L.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2018, 7 (02) : E40 - E42
  • [23] Safety of Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
    Shrestha, Nabin K.
    Blaskewicz, Caitlin
    Gordon, Steven M.
    Everett, Angela
    Rehm, Susan J.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (10): : 1 - 7
  • [24] Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry
    Miron-Rubio, Manuel
    Gonzalez-Ramallo, Victor
    Estrada-Cuxart, Oriol
    Sanroma-Mendizabal, Pedro
    Segado-Soriano, Antonio
    Mujal-Martinez, Abel
    Del Rio-Vizoso, Manuel
    Garcia-Lezcano, Mario
    Martin-Blanco, Natalia
    Florit-Serra, Lidia
    Gil-Bermejo, Merce
    FUTURE MICROBIOLOGY, 2016, 11 (03) : 375 - 390
  • [25] Recent innovations and new applications of outpatient parenteral antimicrobial therapy
    Farmer, Eoghan Charles William
    Seaton, Ronald Andrew
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (01) : 55 - 64
  • [26] Recommendations for outpatient parenteral antimicrobial therapy in Brazil
    Oliveira, Priscila R.
    Carvalho, Vladimir C.
    Cimerman, Sergio
    Munhoz Lima, Ana Lucia
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2017, 21 (06) : 648 - 655
  • [27] Outpatient parenteral antimicrobial therapy with ceftriaxone, a review
    Duncan, Christopher J. A.
    Barr, David A.
    Seaton, R. Andrew
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (03) : 410 - 417
  • [28] Stability of temocillin in outpatient parenteral antimicrobial therapy: is it a real option?
    Fernandez-Rubio, Beatriz
    Herrera-Hidalgo, Laura
    Lopez-Cortes, Luis E.
    Luque-Marquez, Rafael
    De Alarcon, Aristides
    Luque-Pardos, Sonia
    Fernandez-Polo, Aurora
    Gutierrez-Urbon, Jose Maria
    Rodriguez-Bano, Jesus
    Gil-Navarro, Maria Victoria
    Gutierrez-Valencia, Alicia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (10) : 2451 - 2456
  • [29] Outpatient parenteral antimicrobial therapy: how young is too young?
    Hodgson, Kate Alison
    Lim, Ruth
    Huynh, Julie
    Nind, Ben
    Katz, Naomi
    Marlow, Robin
    Hensey, Conor C.
    Scanlan, Barry
    Ibrahim, Laila F.
    Bryant, Penelope A.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2022, 107 (10) : 884 - 889
  • [30] Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists
    Gilchrist, M.
    Seaton, R. A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (04) : 965 - 970